Preclinical evaluation of 89Zr/177Lu/161Tb-labeled anti-CD228 monoclonal antibody for theranostics in skin cutaneous melanoma
- DOI
- 10.1016/j.ejpb.2026.115123
- Published
- 2026-08
- Container
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejpb.2026.115123,
title = {Preclinical evaluation of 89Zr/177Lu/161Tb-labeled anti-CD228 monoclonal antibody for theranostics in skin cutaneous melanoma},
author = {Xiaofei Hao and Huan Du and Binwei Lin and Mingming Tang and Huayan Zhang and Decai Wang and Yihan Zhu and Hu Long and Hanjie Liu and Xiaobo Du},
year = {2026},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
doi = {10.1016/j.ejpb.2026.115123},
url = {https://doi.org/10.1016/j.ejpb.2026.115123}
}RIS
TY - JOUR TI - Preclinical evaluation of 89Zr/177Lu/161Tb-labeled anti-CD228 monoclonal antibody for theranostics in skin cutaneous melanoma AU - Xiaofei Hao AU - Huan Du AU - Binwei Lin AU - Mingming Tang AU - Huayan Zhang AU - Decai Wang AU - Yihan Zhu AU - Hu Long AU - Hanjie Liu AU - Xiaobo Du PY - 2026 JO - European Journal of Pharmaceutics and Biopharmaceutics DO - 10.1016/j.ejpb.2026.115123 UR - https://doi.org/10.1016/j.ejpb.2026.115123 ER -
APA
Hao, X., Du, H., Lin, B., Tang, M., Zhang, H., Wang, D., Zhu, Y., Long, H., Liu, H., & Du, X. (2026). Preclinical evaluation of 89Zr/177Lu/161Tb-labeled anti-CD228 monoclonal antibody for theranostics in skin cutaneous melanoma. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115123
Source records
- crossref · retrieved 2026-09-27T02:12:42.820Z